Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment

Purpose: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness related to oxygen exposure in premature infants. Since oxygen monitoring protocols have reduced the incidence of treatment-requiring ROP (TR-ROP), it remains unclear whether oxygen exposure remains a relevant risk fa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jimmy S. Chen, MD, Jamie E. Anderson, BS, Aaron S. Coyner, PhD, Susan Ostmo, MS, Kemal Sonmez, PhD, Deniz Erdogmus, PhD, Brian K. Jordan, MD, PhD, Cynthia T. McEvoy, MD, MCR, Dmitry Dukhovny, MD, MPH, Robert L. Schelonka, MD, R.V. Paul Chan, MD, Praveer Singh, PhD, Jayashree Kalpathy-Cramer, PhD, Michael F. Chiang, MD, MA, J. Peter Campbell, MD, MPH
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/3512bd76c0314624885dea900dad53bd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3512bd76c0314624885dea900dad53bd
record_format dspace
spelling oai:doaj.org-article:3512bd76c0314624885dea900dad53bd2021-12-04T04:36:27ZQuantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment2666-914510.1016/j.xops.2021.100070https://doaj.org/article/3512bd76c0314624885dea900dad53bd2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666914521000683https://doaj.org/toc/2666-9145Purpose: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness related to oxygen exposure in premature infants. Since oxygen monitoring protocols have reduced the incidence of treatment-requiring ROP (TR-ROP), it remains unclear whether oxygen exposure remains a relevant risk factor for incident TR-ROP and aggressive ROP (A-ROP), a severe, rapidly progressing form of ROP. The purpose of this proof-of-concept study was to use electronic health record (EHR) data to evaluate early oxygen exposure as a predictive variable for developing TR-ROP and A-ROP. Design: Retrospective cohort study. Participants: Two hundred forty-four infants screened for ROP at a single academic center. Methods: For each infant, oxygen saturations and fraction of inspired oxygen (FiO2) were extracted manually from the EHR until 31 weeks postmenstrual age (PMA). Cumulative minimum, maximum, and mean oxygen saturation and FiO2 were calculated on a weekly basis. Random forest models were trained with 5-fold cross-validation using gestational age (GA) and cumulative minimum FiO2 at 30 weeks PMA to identify infants who developed TR-ROP. Secondary receiver operating characteristic (ROC) curve analysis of infants with or without A-ROP was performed without cross-validation because of small numbers. Main Outcome Measures: For each model, cross-validation performance for incident TR-ROP was assessed using area under the ROC curve (AUC) and area under the precision-recall curve (AUPRC) scores. For A-ROP, we calculated AUC and evaluated sensitivity and specificity at a high-sensitivity operating point. Results: Of the 244 infants included, 33 developed TR-ROP, of which 5 developed A-ROP. For incident TR-ROP, random forest models trained on GA plus cumulative minimum FiO2 (AUC = 0.93 ± 0.06; AUPRC = 0.76 ± 0.08) were not significantly better than models trained on GA alone (AUC = 0.92 ± 0.06 [P = 0.59]; AUPRC = 0.74 ± 0.12 [P = 0.32]). Models using oxygen alone showed an AUC of 0.80 ± 0.09. ROC analysis for A-ROP found an AUC of 0.92 (95% confidence interval, 0.87–0.96). Conclusions: Oxygen exposure can be extracted from the EHR and quantified as a risk factor for incident TR-ROP and A-ROP. Extracting quantifiable clinical features from the EHR may be useful for building risk models for multiple diseases and evaluating the complex relationships among oxygen exposure, ROP, and other sequelae of prematurity.Jimmy S. Chen, MDJamie E. Anderson, BSAaron S. Coyner, PhDSusan Ostmo, MSKemal Sonmez, PhDDeniz Erdogmus, PhDBrian K. Jordan, MD, PhDCynthia T. McEvoy, MD, MCRDmitry Dukhovny, MD, MPHRobert L. Schelonka, MDR.V. Paul Chan, MDPraveer Singh, PhDJayashree Kalpathy-Cramer, PhDMichael F. Chiang, MD, MAJ. Peter Campbell, MD, MPHElsevierarticleElectronic health recordsMachine learningOxygen exposureRetinopathy of prematurityOphthalmologyRE1-994ENOphthalmology Science, Vol 1, Iss 4, Pp 100070- (2021)
institution DOAJ
collection DOAJ
language EN
topic Electronic health records
Machine learning
Oxygen exposure
Retinopathy of prematurity
Ophthalmology
RE1-994
spellingShingle Electronic health records
Machine learning
Oxygen exposure
Retinopathy of prematurity
Ophthalmology
RE1-994
Jimmy S. Chen, MD
Jamie E. Anderson, BS
Aaron S. Coyner, PhD
Susan Ostmo, MS
Kemal Sonmez, PhD
Deniz Erdogmus, PhD
Brian K. Jordan, MD, PhD
Cynthia T. McEvoy, MD, MCR
Dmitry Dukhovny, MD, MPH
Robert L. Schelonka, MD
R.V. Paul Chan, MD
Praveer Singh, PhD
Jayashree Kalpathy-Cramer, PhD
Michael F. Chiang, MD, MA
J. Peter Campbell, MD, MPH
Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment
description Purpose: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness related to oxygen exposure in premature infants. Since oxygen monitoring protocols have reduced the incidence of treatment-requiring ROP (TR-ROP), it remains unclear whether oxygen exposure remains a relevant risk factor for incident TR-ROP and aggressive ROP (A-ROP), a severe, rapidly progressing form of ROP. The purpose of this proof-of-concept study was to use electronic health record (EHR) data to evaluate early oxygen exposure as a predictive variable for developing TR-ROP and A-ROP. Design: Retrospective cohort study. Participants: Two hundred forty-four infants screened for ROP at a single academic center. Methods: For each infant, oxygen saturations and fraction of inspired oxygen (FiO2) were extracted manually from the EHR until 31 weeks postmenstrual age (PMA). Cumulative minimum, maximum, and mean oxygen saturation and FiO2 were calculated on a weekly basis. Random forest models were trained with 5-fold cross-validation using gestational age (GA) and cumulative minimum FiO2 at 30 weeks PMA to identify infants who developed TR-ROP. Secondary receiver operating characteristic (ROC) curve analysis of infants with or without A-ROP was performed without cross-validation because of small numbers. Main Outcome Measures: For each model, cross-validation performance for incident TR-ROP was assessed using area under the ROC curve (AUC) and area under the precision-recall curve (AUPRC) scores. For A-ROP, we calculated AUC and evaluated sensitivity and specificity at a high-sensitivity operating point. Results: Of the 244 infants included, 33 developed TR-ROP, of which 5 developed A-ROP. For incident TR-ROP, random forest models trained on GA plus cumulative minimum FiO2 (AUC = 0.93 ± 0.06; AUPRC = 0.76 ± 0.08) were not significantly better than models trained on GA alone (AUC = 0.92 ± 0.06 [P = 0.59]; AUPRC = 0.74 ± 0.12 [P = 0.32]). Models using oxygen alone showed an AUC of 0.80 ± 0.09. ROC analysis for A-ROP found an AUC of 0.92 (95% confidence interval, 0.87–0.96). Conclusions: Oxygen exposure can be extracted from the EHR and quantified as a risk factor for incident TR-ROP and A-ROP. Extracting quantifiable clinical features from the EHR may be useful for building risk models for multiple diseases and evaluating the complex relationships among oxygen exposure, ROP, and other sequelae of prematurity.
format article
author Jimmy S. Chen, MD
Jamie E. Anderson, BS
Aaron S. Coyner, PhD
Susan Ostmo, MS
Kemal Sonmez, PhD
Deniz Erdogmus, PhD
Brian K. Jordan, MD, PhD
Cynthia T. McEvoy, MD, MCR
Dmitry Dukhovny, MD, MPH
Robert L. Schelonka, MD
R.V. Paul Chan, MD
Praveer Singh, PhD
Jayashree Kalpathy-Cramer, PhD
Michael F. Chiang, MD, MA
J. Peter Campbell, MD, MPH
author_facet Jimmy S. Chen, MD
Jamie E. Anderson, BS
Aaron S. Coyner, PhD
Susan Ostmo, MS
Kemal Sonmez, PhD
Deniz Erdogmus, PhD
Brian K. Jordan, MD, PhD
Cynthia T. McEvoy, MD, MCR
Dmitry Dukhovny, MD, MPH
Robert L. Schelonka, MD
R.V. Paul Chan, MD
Praveer Singh, PhD
Jayashree Kalpathy-Cramer, PhD
Michael F. Chiang, MD, MA
J. Peter Campbell, MD, MPH
author_sort Jimmy S. Chen, MD
title Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment
title_short Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment
title_full Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment
title_fullStr Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment
title_full_unstemmed Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment
title_sort quantification of early neonatal oxygen exposure as a risk factor for retinopathy of prematurity requiring treatment
publisher Elsevier
publishDate 2021
url https://doaj.org/article/3512bd76c0314624885dea900dad53bd
work_keys_str_mv AT jimmyschenmd quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT jamieeandersonbs quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT aaronscoynerphd quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT susanostmoms quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT kemalsonmezphd quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT denizerdogmusphd quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT briankjordanmdphd quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT cynthiatmcevoymdmcr quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT dmitrydukhovnymdmph quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT robertlschelonkamd quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT rvpaulchanmd quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT praveersinghphd quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT jayashreekalpathycramerphd quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT michaelfchiangmdma quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
AT jpetercampbellmdmph quantificationofearlyneonataloxygenexposureasariskfactorforretinopathyofprematurityrequiringtreatment
_version_ 1718372904190607360